|
Dylan P. Blacquiere, MD
(The Ottawa Hospital of Medicine, University of Ottawa)
|
Dr. Blacquiere has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Blacquiere has a non-compensated relationship as a Board of Directors with Canadian Stroke Consortium that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Blacquiere has a non-compensated relationship as a Advisory Board Member with Heart and Stroke Foundationof Canada Stroke Best Practice Recommendations that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
|
Mike Sharma, MD
(Population Health Research Institute)
|
Dr. Sharma has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bayer. Dr. Sharma has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Regeneron. Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anthos. Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. The institution of Dr. Sharma has received research support from Bayer. |